pubrio
Variational AI

Variational AI

Canada · Research

Research

Pharmaceuticals

Biotechnology

Information Technology

Variational AI specializes in using generative AI to accelerate drug discovery by generating novel, synthesizable small molecules. Their platform, Enki™, enables rapid exploration of chemical space, optimizing for multiple objectives such as potency, selectivity, and safety. This approach transforms the cost, speed, and scope of drug discovery, particularly in oncology. By generating new molecules de novo, they eliminate the need for extensive screening libraries.

Company Insights
Company Overview

2019

Founded

Research

Industry

Canada

Location

2,777,285

Ranking

22 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Variational AI

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​